RAAS Inhibitor Drugs in Dialysis Patients

Summary

Hypertensive haemodialysis patients are at high risk for cardiovascular events. This study was undertaken to ascertain whether the upstream of aliskirne, a direct renin inhibitor improves mortality and cardiovascular outcomes in these high-risk population.

Timeline

Start

2010-02

Primary completion

2012-09

Completion

2012-09

Drugs

Indications